Patents by Inventor Britta Deutel

Britta Deutel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation comprising a biopharmaceutical drug
    Patent number: 9480743
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: November 1, 2016
    Assignee: Hexal AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Fürtinger, Bernt Pragl, Drago Kuzman
  • Stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc
    Patent number: 9453067
    Abstract: The present invention relates to stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc comprising different buffer systems and stabilizers. In particular, it could be demonstrated that the physical stability of TNFR:Fc is significantly improved by using a citrate buffer system and lysine as stabilizer.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: September 27, 2016
    Assignee: Sandoz AG
    Inventors: Britta Deutel, Thomas Lauber, Sabine Fuertinger
  • PHARMACEUTICAL FORMULATION COMPRISING A BIOPHARMACEUTICAL DRUG
    Publication number: 20130336968
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Application
    Filed: December 28, 2011
    Publication date: December 19, 2013
    Applicant: HEXAL AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Furtinger, Bernt Pragl, Drago Kuzman